Skip to main content

Table 4 Illustration of the reported therapeutic targets that are regulated by LHR activation

From: Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation

Type

Target name

LHR+

LH1

LH4

LH8

LH20

Research

Endothelin-1 (ET-1)

-1.1

10.2

4.3

1.8

2.1

Research

Stromal cell-derived factor 1 (SCD-1)

1.2

1.6

10.3

6.3

4.2

Research

Insulin-like growth factor II (IGF2)

-8.7

8.6

11.6

3.9

9.2

Clinical trail

Kinesin-like protein KIF11 (KIF11)

-1.5

-1.1

-2.3

-1.3

-1.6

  1. Fold changes are shown; the category (successful, clinical trial or research) indicates the different phase of the therapeutic targets discovery.